First Medical Contact-to-Device Time and Heart Failure Outcomes Among Patients Undergoing Primary Percutaneous

Joshua P Loh1,2, Li-Ling Tan1, Huili Zheng3

  • 1National University Heart Centre Singapore (J.P.L., L.-L.T., H-C.T., A.M.R., M.Y.C.).

Insights

Expediting reperfusion therapy for ST-segment-elevation myocardial infarction patients reduced in-hospital heart failure (HF). However, delays in reperfusion beyond 90 minutes increased 30-day HF rehospitalization for those with existing HF.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Heart Failure Research

Background:

  • Primary percutaneous coronary intervention (PCI) aims to salvage myocardium in ST-segment-elevation myocardial infarction (STEMI) by expediting reperfusion.
  • Limited research exists on the correlation between reperfusion time and subsequent heart failure (HF) events.

Purpose of the Study:

  • To investigate the association between the time from first medical contact to device deployment (FTD) and heart failure events in STEMI patients undergoing primary PCI.
  • To analyze trends in FTD, in-hospital HF, and HF rehospitalization over a seven-year period.

Main Methods:

  • A retrospective analysis of 7597 patients undergoing primary PCI between 2007 and 2013 was conducted using the Singapore Myocardial Infarct Registry.
  • The study examined the relationship between FTD time and in-hospital HF events and HF rehospitalization, with mortality as a competing risk.
  • Individual-level data was analyzed to assess the impact of FTD duration on HF outcomes.

Main Results:

  • Median FTD time significantly decreased from 91 to 58 minutes between 2007 and 2013 (P=0.001), while overall mortality remained stable.
  • Heart failure at admission increased (12.2% to 18.4%), but post-admission in-hospital HF decreased (12.8% to 7.1%).
  • HF rehospitalization rates increased significantly for both 30-day (1.2% to 2.6%) and 1-year (3.8% to 5.6%) periods. Longer FTD times were associated with increased risk of post-admission HF and 30-day HF rehospitalization, particularly delays exceeding 90 minutes.

Conclusions:

  • Temporal reductions in FTD time were linked to a decrease in post-admission in-hospital HF.
  • For patients presenting with HF at admission, FTD delays exceeding 90 minutes were associated with a higher incidence of 30-day HF rehospitalization.

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
319
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
501
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
929
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.7K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
886
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
340